Literature DB >> 25263595

NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis.

Jonathan D Brown1, Charles Y Lin2, Qiong Duan1,3, Gabriel Griffin4, Alexander Federation2, Ronald M Paranal2, Steven Bair4, Gail Newton4, Andrew Lichtman4, Andrew Kung2,5, Tianlun Yang3, Hong Wang1, Francis W Luscinskas4, Kevin Croce1, James E Bradner2, Jorge Plutzky1.   

Abstract

Proinflammatory stimuli elicit rapid transcriptional responses via transduced signals to master regulatory transcription factors. To explore the role of chromatin-dependent signal transduction in the atherogenic inflammatory response, we characterized the dynamics, structure, and function of regulatory elements in the activated endothelial cell epigenome. Stimulation with tumor necrosis factor alpha prompted a dramatic and rapid global redistribution of chromatin activators to massive de novo clustered enhancer domains. Inflammatory super enhancers formed by nuclear factor-kappa B accumulate at the expense of immediately decommissioned, basal endothelial super enhancers, despite persistent histone hyperacetylation. Mass action of enhancer factor redistribution causes momentous swings in transcriptional initiation and elongation. A chemical genetic approach reveals a requirement for BET bromodomains in communicating enhancer remodeling to RNA Polymerase II and orchestrating the transition to the inflammatory cell state, demonstrated in activated endothelium and macrophages. BET bromodomain inhibition abrogates super enhancer-mediated inflammatory transcription, atherogenic endothelial responses, and atherosclerosis in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25263595      PMCID: PMC4224636          DOI: 10.1016/j.molcel.2014.08.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  43 in total

1.  A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition.

Authors:  A Dey; J Ellenberg; A Farina; A E Coleman; T Maruyama; S Sciortino; J Lippincott-Schwartz; K Ozato
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.

Authors:  Bo Huang; Xiao-Dong Yang; Ming-Ming Zhou; Keiko Ozato; Lin-Feng Chen
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

Review 3.  Control of NF-kappaB-dependent transcriptional responses by chromatin organization.

Authors:  Gioacchino Natoli
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

4.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

5.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

6.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors.

Authors:  Sarah De Val; Neil C Chi; Stryder M Meadows; Simon Minovitsky; Joshua P Anderson; Ian S Harris; Melissa L Ehlers; Pooja Agarwal; Axel Visel; Shan-Mei Xu; Len A Pennacchio; Inna Dubchak; Paul A Krieg; Didier Y R Stainier; Brian L Black
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

8.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

9.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

Authors:  Minna U Kaikkonen; Nathanael J Spann; Sven Heinz; Casey E Romanoski; Karmel A Allison; Joshua D Stender; Hyun B Chun; David F Tough; Rab K Prinjha; Christopher Benner; Christopher K Glass
Journal:  Mol Cell       Date:  2013-08-08       Impact factor: 17.970

10.  A high-resolution map of the three-dimensional chromatin interactome in human cells.

Authors:  Fulai Jin; Yan Li; Jesse R Dixon; Siddarth Selvaraj; Zhen Ye; Ah Young Lee; Chia-An Yen; Anthony D Schmitt; Celso A Espinoza; Bing Ren
Journal:  Nature       Date:  2013-10-20       Impact factor: 49.962

View more
  265 in total

1.  Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.

Authors:  Beatriz Suarez-Alvarez; José Luis Morgado-Pascual; Sandra Rayego-Mateos; Ramon M Rodriguez; Raul Rodrigues-Diez; Pablo Cannata-Ortiz; Ana B Sanz; Jesus Egido; Pierre-Louis Tharaux; Alberto Ortiz; Carlos Lopez-Larrea; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2016-07-19       Impact factor: 10.121

Review 2.  Genome-Wide Approaches to Defining Macrophage Identity and Function.

Authors:  Gregory J Fonseca; Jason S Seidman; Christopher K Glass
Journal:  Microbiol Spectr       Date:  2016-10

3.  Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape.

Authors:  Behnam Nabet; Pilib Ó Broin; Jaime M Reyes; Kevin Shieh; Charles Y Lin; Christine M Will; Relja Popovic; Teresa Ezponda; James E Bradner; Aaron A Golden; Jonathan D Licht
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

Review 4.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 5.  Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis.

Authors:  Nathan M Krah; L Charles Murtaugh
Journal:  Trends Cancer       Date:  2016-12

Review 6.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

Authors:  Satyaki Sengupta; Rani E George
Journal:  Trends Cancer       Date:  2017-04-12

7.  BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy.

Authors:  Andrew Antolic; Hiroko Wakimoto; Zhe Jiao; Joshua M Gorham; Steven R DePalma; Madeleine E Lemieux; David A Conner; Da Young Lee; Jun Qi; Jonathan G Seidman; James E Bradner; Jonathan D Brown; Saptarsi M Haldar; Christine E Seidman; Michael A Burke
Journal:  JCI Insight       Date:  2020-08-06

8.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

9.  RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation.

Authors:  Homa Rahnamoun; Jihoon Lee; Zhengxi Sun; Hanbin Lu; Kristen M Ramsey; Elizabeth A Komives; Shannon M Lauberth
Journal:  Nat Struct Mol Biol       Date:  2018-08-03       Impact factor: 15.369

10.  Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.

Authors:  David Gosselin; Verena M Link; Casey E Romanoski; Gregory J Fonseca; Dawn Z Eichenfield; Nathanael J Spann; Joshua D Stender; Hyun B Chun; Hannah Garner; Frederic Geissmann; Christopher K Glass
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.